Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab

• Main Authors: Ellis LA (Author), Malangone-Monaco E (Author), Varker H (Author), Stetsovsky D (Author), Kubacki M (Author), DeHoratius RJ (Author), Kafka S (Author)
• Format: Book
• Published: Dove Medical Press, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lorie A Ellis,1 Elisabetta Malangone-Monaco,2 Helen Varker,3 Diana Stetsovsky,3 Maureen Kubacki,1 Raphael J DeHoratius,1,4 Shelly Kafka1 1Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA; 2Life Sciences, IBM Watson Health, Armonk, NY, USA; 3Life Sciences, IBM Watson H...